FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

PH Pikkarainen

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Markku Heikkinen; PH Pikkarainen; M Vornanen; S Hollmén; Risto Julkunen
Prevalence of gastric metaplasia in the duodenal bulb is low in Helicobacter pylori positive non-ulcer dyspepsia patients.
Markku Heikkinen; PH Pikkarainen; M Eskelinen; Risto Julkunen
GPs' ability to diagnose dyspepsia based only on physical examination and patient history.
Esko Janatuinen; Tarja Kemppainen; PH Pikkarainen; K H Holm; Veli-Matti Kosma; M I J Uusitupa; Markku Mäki; Risto Julkunen
Lack of cellular and humoral immunological responses to oats in adults with coeliac disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of PH Pikkarainen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Markku Heikkinen; PH Pikkarainen; M Vornanen; S Hollmén; Risto Julkunen
Prevalence of gastric metaplasia in the duodenal bulb is low in Helicobacter pylori positive non-ulcer dyspepsia patients.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2001;33(6):459-63.
2000: Markku Heikkinen; PH Pikkarainen; M Eskelinen; Risto Julkunen
GPs' ability to diagnose dyspepsia based only on physical examination and patient history.
Scandinavian journal of primary health care 2000;18(2):99-104.
2000: Esko Janatuinen; Tarja Kemppainen; PH Pikkarainen; K H Holm; Veli-Matti Kosma; M I J Uusitupa; Markku Mäki; Risto Julkunen
Lack of cellular and humoral immunological responses to oats in adults with coeliac disease.
Gut 2000;46(3):327-31.
1999: Tarja Kemppainen; Heikki Kröger; Esko Janatuinen; I Arnala; Veli-Matti Kosma; PH Pikkarainen; Risto Julkunen; Jukka S Jurvelin; Esko Alhava; Matti Uusitupa
Osteoporosis in adult patients with celiac disease.
Bone 1999;24(3):249-55.
1998: Tarja Kemppainen; Veli-Matti Kosma; Esko Janatuinen; Risto Julkunen; PH Pikkarainen; M I J Uusitupa
Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet--association with the grade of mucosal villous atrophy.
The American journal of clinical nutrition 1998;67(3):482-7.
1998: Markku Heikkinen; K Mayo; F Mégraud; M Vornanen; S Marin; PH Pikkarainen; Risto Julkunen
Association of CagA-positive and CagA-negative Helicobacter pylori strains with patients' symptoms and gastritis in primary care patients with functional upper abdominal complaints.
Scandinavian journal of gastroenterology 1998;33(1):31-8.
1997: Markku Heikkinen; Esko Janatuinen; K Mayo; F Mégraud; Risto Julkunen; PH Pikkarainen
Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy.
The American journal of gastroenterology 1997;92(12):2225-9.
1997: M T Heikkinen; PH Pikkarainen; J K Takala; H T Räsänen; M J Eskelinen; Risto Julkunen
Diagnostic methods in dyspepsia: the usefulness of upper abdominal ultrasound and gastroscopy.
Scandinavian journal of primary health care 1997;15(2):82-6.
1996: Markku Heikkinen; PH Pikkarainen; J Takala; Risto Julkunen
General practitioners' approach to dyspepsia. Survey of consultation frequencies, treatment, and investigations.
Scandinavian journal of gastroenterology 1996;31(7):648-53.
1995: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttilä; Esko Alhava
Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
Anticancer research 1995;15(6B):2731-7.
1995: Esko Janatuinen; PH Pikkarainen; Tarja Kemppainen; Veli-Matti Kosma; R M Järvinen; M I J Uusitupa; Risto Julkunen
A comparison of diets with and without oats in adults with celiac disease.
The New England journal of medicine 1995;333(16):1033-7.
1995: Tarja Kemppainen; Matti Uusitupa; Esko Janatuinen; Ritva Järvinen; Risto Julkunen; PH Pikkarainen
Intakes of nutrients and nutritional status in coeliac patients.
Scandinavian journal of gastroenterology 1995;30(6):575-9.
1995: Markku Heikkinen; PH Pikkarainen; J Takala; H Räsänen; Risto Julkunen
Etiology of dyspepsia: four hundred unselected consecutive patients in general practice.
Scandinavian journal of gastroenterology 1995;30(6):519-23.
1994: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttilä; Esko Alhava
A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
British journal of cancer 1994;69(3):562-5.
1994: P A Pasanen; K Partanen; PH Pikkarainen; Esko Alhava; A Pirinen; Esko Janatuinen
A prospective study on the value of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the diagnosis of unjaundiced cholestasis.
In vivo (Athens, Greece) 1994;8(2):227-30.
1994: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttilä; Esko Alhava
Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma.
Journal of cancer research and clinical oncology 1994;120(8):494-7.
1994: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttilä; Esko Alhava
Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(1):52-60.
1993: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttila
Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Anticancer research 1993;13(5C):1883-7.
1993: P A Pasanen; PH Pikkarainen; Esko Alhava; K Partanen; Esko Janatuinen
Evaluation of a computer-based diagnostic score system in the diagnosis of jaundice and cholestasis.
Scandinavian journal of gastroenterology 1993;28(8):732-6.
1993: Esko Janatuinen; PH Pikkarainen; M Laakso; K Pyörälä
Gastrointestinal symptoms in middle-aged diabetic patients.
Scandinavian journal of gastroenterology 1993;28(5):427-32.
1993: P A Pasanen; Risto A Kauppinen; Matti Eskelinen; K Partanen; PH Pikkarainen; Esko Alhava
The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
Anticancer research 1993;13(3):763-8.
1993: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttilä; Esko Alhava
Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.
British journal of cancer 1993;67(4):852-5.
1993: P Pasanen; PH Pikkarainen; E Alhava; K Partanen; I Penttilä
Value of serum alkaline phosphatase, aminotransferases, gamma-glutamyl transferase, leucine aminopeptidase, and bilirubin in the distinction between benign and malignant diseases causing jaundice and cholestasis: results from a prospective study.
Scandinavian journal of clinical and laboratory investigation 1993;53(1):35-9.
1993: P A Pasanen; Risto A Kauppinen; Matti Eskelinen; K P Partanen; PH Pikkarainen; Esko M Alhava
Nuclear magnetic resonance spectroscopy of plasma to distinguish between malignant and benign diseases causing jaundice and cholestasis.
Journal of cancer research and clinical oncology 1993;119(10):622-6.
1993: P A Pasanen; K P Partanen; PH Pikkarainen; Esko M Alhava; Esko Janatuinen; A E Pirinen
A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis.
The European journal of surgery = Acta chirurgica 1993;159(1):23-9.
1993: Esko Janatuinen; PH Pikkarainen; M Vornanen; M Suhonen; K Launiala
[Caroli's disease and congenital liver fibrosis].
Duodecim; lääketieteellinen aikakauskirja 1993;109(9):739-45.
1992: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttilä; Esko Alhava
A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients.
Anticancer research 1992;12(6B):2309-14.
1992: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttilä; Esko Alhava
Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study.
Anticancer research 1992;12(5):1687-93.
1992: P A Pasanen; PH Pikkarainen; Esko Alhava; K Partanen; A Pirinen; Esko Janatuinen
The value of clinical assessment in the diagnosis of icterus and cholestasis.
The Italian journal of gastroenterology 1992;24(6):313-9.
1992: P Pasanen; K Partanen; PH Pikkarainen; Esko Alhava; A Pirinen; Esko Janatuinen
Diagnostic accuracy of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the detection of pancreatic cancer in patients with jaundice or cholestasis.
In vivo (Athens, Greece) 1992;6(3):297-301.
1992: P A Pasanen; Matti Eskelinen; K Partanen; PH Pikkarainen; I Penttilä; Esko Alhava
Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
British journal of cancer 1992;65(5):731-4.
1992: P Pasanen; K Partanen; PH Pikkarainen; Esko Alhava; A Pirinen; Esko Janatuinen
Ultrasonography, CT, and ERCP in the diagnosis of choledochal stones.
Acta radiologica (Stockholm, Sweden : 1987) 1992;33(1):53-6.
1992: P Pasanen; K Partanen; PH Pikkarainen; Esko Alhava; A Pirinen; Esko Janatuinen
Complications of endoscopic retrograde cholangiopancreatography in jaundiced and cholestatic patients.
Annales chirurgiae et gynaecologiae 1992;81(1):28-31.
1992: P Pasanen; K Partanen; PH Pikkarainen; Esko Alhava
Characteristics of jaundice and cholestasis in a Finnish population.
Annales chirurgiae et gynaecologiae 1992;81(3):284-9.
1991: P A Pasanen; K Partanen; PH Pikkarainen; Esko Alhava; A Pirinen; Esko Janatuinen
Diagnostic accuracy of ultrasound, computed tomography, and endoscopic retrograde cholangiopancreatography in the detection of obstructive jaundice.
Scandinavian journal of gastroenterology 1991;26(11):1157-64.
1991: F Chang; Esko Janatuinen; PH Pikkarainen; Stina Syrjänen; Kari Syrjänen
Esophageal squamous cell papillomas. Failure to detect human papillomavirus DNA by in situ hybridization and polymerase chain reaction.
Scandinavian journal of gastroenterology 1991;26(5):535-43.
1991: MT Vidgren; Timo Petteri Paronen; K Bergström; P Vainio; PH Pikkarainen
Deposition and gastrointestinal transit of conventional sucralfate tablets.
Acta pharmaceutica Nordica 1991;3(2):83-6.
1990: K Partanen; PH Pikkarainen; P Pasanen; E Alhava; Seppo Soimakallio
Ultrasonography and computed tomography in diffuse liver disease with cholestasis.
Acta radiologica (Stockholm, Sweden : 1987) 1990;31(5):477-82.
1989: M Paakkonen; S Aukee; Esko Janatuinen; J Lahtinen; F Laxen; M Olsen; PH Pikkarainen; E Poikolainen
Sucralfate as maintenance treatment for the prevention of duodenal ulcer recurrence.
The American journal of medicine 1989;86(6A):133-5.